In bispecific rivalry, AbbVie’s Epkinly follows Roche’s Lunsumio into follicular lymphoma

27th June 2024 Uncategorised 0

In bispecific rivalry, AbbVie’s Epkinly follows Roche’s Lunsumio into follicular lymphoma
aliu
Thu, 06/27/2024 – 09:58

More: In bispecific rivalry, AbbVie’s Epkinly follows Roche’s Lunsumio into follicular lymphoma
Source: fierce